Navigation Links
Caloric Restriction in Non-obese People Extends Life Span

chieved by diet alone or by diet plus exercise, decreased 24hr whole body energy expenditure (i.e. overall calories burned), which suggests improved mitochondrial function. Their analysis of genes involved in mitochondria formation indicated that CR and CREX both increased the number of mitochondria in muscle. Both interventions also reduced the amount of DNA damage—a marker of oxidative stress—in the participants' muscles.

The researchers also examined gene expression in the study participants. In yeast, worms, and flies the activation of the Sir2 gene increases life span and regulates cellular metabolism. An important question is whether caloric restriction can regulate SIRT1 (the mammalian equivalent of Sir2) in humans. Civitarese and colleagues found that indeed fewer calories can improve whole body metabolism in conjunction with an increase in SIRT1 gene expression in skeletal muscle. These results raise the possibility that SIRT1 may contribute to more efficient metabolism, less oxidative stress, and increase longevity in humans as it does in lower organism.

The results suggest that even short-term caloric restriction can produce beneficial physiological changes leading to improved health. Whether caloric restriction and the associated health benefits can be sustained over longer term remains to be established in humans.

Source-Eurekalert
RI
'"/>




Page: 1 2

Related medicine news :

1. Progression Of ALS May Be Prevented By A High Caloric Diet
2. FDA Imposes New Restrictions On Roches Accutane
3. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
4. Bird Flu Restrictions To Be Lifted In Scotland
5. Restriction of Carbohydrates to Prevent Alzheimers Disease
6. No More Dietary Restriction for Heartburn Patients - Study Says
7. Liberated British Mothers Want No Restriction on Breast Feeding In Public
8. Restrictions Imposed on Sale of Edible Common Salt
9. Bush Supports Restriction to ‘Morning–After’ Pll
10. Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog
11. Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel
Post Your Comments:
(Date:7/25/2008)...s second quarter financial results -, LAVAL, QC, ...SX: DDS;,NASDAQ: DDSS) today announced that it wil...30 a.m. (ET) to discuss its second quarter 2008,fi...quarter 2008 financial,results via news release at... the conference call by telephone, dial 416-646-30...
(Date:7/25/2008)...oducts reduces lung function, increases asthma ris...(HealthDay News) -- A clean, fresh-smelling home m...hat type of cleaning and air freshening products y...e to cleaning products or air fresheners that cont...ed 1,4 dicholorobenzene (1,4 DCB), can reduce lung...
(Date:7/25/2008)...swire/ -- BeaconEquity.com announces the,availabil... Investors can view all of the daily trading notes..., Today,s Trade Alerts include: DUSA Pharmaceutic...cals Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,...nc. (Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABA...
(Date:7/25/2008)... of Marketing Exclusivity Begins -, CORONA, Calif...ceuticals, Inc. (NYSE: WPI ), a leading specialty...subsidiary has commenced commercial,shipment of it...in the 40mg,strength from its Davie, Florida manuf... Watson has 180 days of marketing exclusivity for ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
...1,000 pounds a measure. Available at the main bar...ie Walker 1805 has just gone on sale. It is claime...ave been made to celebrate the birthday of the lab...arcity value has been enhanced, the makers claim, ...
...kness (AMS), which affects about half of those asc...hreatening complications such as pulmonary or cere...AMS is thought to have increased over the past 25 ...media exposure, trekking guidebooks and the wide a...
...tish Youngman willingly came forward to donate mor...ansplant has been successful. David and Stephen ...r The 20-year-old David Lomas from Cumbria said he...y when his father Stephen, 51, asked for it. <...
... 2003 have not absorbed dangerous levels of deplet...t in Occupational and Environmental Medicine. De...e armoured vehicles, and spontaneously combusts on... These can either be breathed in or eaten/drunk in...
Other Medicine News:Health News:Scot's National Drink, Now Available at 1,000 Pounds a Nip 2Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Son Donates Part of Liver to Ailing Father, Transplant Successful 2
(Date:7/24/2008)...e-Clinical Data Shows Increased Muscle and Blood V...als, Hearts, SUNRISE, Fla., July 24 /PRNewswire-F...ing the injection of myoblasts modified to express...nto the scar tissue of the,myocardium of rats, whi...presented at two scientific meetings -- the Intern...
(Date:7/24/2008)... New JIT Enrollment Program Speeds Oncology Pat...rmatech, Inc., a Research Management,Organization ...ical,companies to provide research and site manage...Just-in-Time (JIT) enrollment strategy. The new,tr...llicular Non-Hodgkin,s,Lymphoma, Metastatic Breast...
(Date:7/23/2008)... Nexavar is First Approved Systemic Therapy to Tre...if., July 23 /-,Bayer Healt...c. (Nasdaq:,ONXX) today announced that The New Eng...ase 3 trial demonstrating that Nexavar(R) (sorafen...y 31 percent in patients with,unresectable hepatoc...
(Date:7/23/2008)...OSTON, July 23 /- FluoroPharma Inc., ...g agents for the Positron Emission Tomography,(PET...FPET, its novel,Fluorine-18 labeled tracer for myo... second cardiovascular product to complete Phase I...ent, designed to assess the blood flow in the,hear...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 1Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 1Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 3Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 1Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 2BRCA Mutations Dont Spot All High Risk Women 18375 1BRCA Mutations Dont Spot All High Risk Women 18375 2BRCA Mutations Dont Spot All High Risk Women 18375 3
...tudy Results Presented at Society of Nuclear,Medic...RNewswire-FirstCall/ --,Immunomedics, Inc. , a bio...lonal antibodies to treat cancer and other serious...bryonic antigen,(CEA) antibody, labetuzumab, label... be safe and active when given in two doses,to pat...
...IRE)--Jun 4, 2007 - Pfizer announced today that,ax...tive inhibitor,of VEGFR 1, 2,3 (vascular endotheli...gemcitabine showed a trend towards prolonged,overa...tic cancer,compared with gemcitabine alone, accor...I trial., These data were presented at the 43rd Am...
Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 2New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 3New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: